We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Avelox to Treat Pneumonic, Septicemetic Plagues
FDA Approves Avelox to Treat Pneumonic, Septicemetic Plagues
The FDA Friday approved Bayer HealthCare’s Avelox for the treatment of pneumonic and septicemetic plague, under the animal efficacy rule. It also is approved to prevent plague in adults.